Silo Pharma, Inc. Common Stock
Symbol: SILO (NASDAQ)
0.56
▼ (-2.28%) -0.013
Company Description:
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Key Stats
- Today's Open: $0.5682
- Today's High: $0.569
- Today's Low: $0.547
- Today's Volume: 55.24K
- Yesterday Close: $0.5751
- Yesterday High: $0.577
- Yesterday Low: $0.555
- Yesterday Volume: 222.87K
- Last Min Volume: 296
- Last Min High: $0.562
- Last Min Low: $0.562
- Last Min VWAP: $0.562
Company Profile
- Name: Silo Pharma, Inc. Common Stock
- Website: https://www.silopharma.com
- Listed Date: 2012-01-05
- Location: SARASOTA, FL
- Market Status: Active
- CIK Number: 0001514183
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.52M
- Round Lot: 100
- Outstanding Shares: 13.32M
- Asset Type: CS
RECENT FILINGS FOR SILO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-03 | SCHEDULE 13G | View |
| 2025-10-01 | 8-K | View |
| 2025-10-01 | 424B5 | View |
| 2025-09-05 | DEFA14A | View |
| 2025-09-05 | ARS | View |
| 2025-09-05 | DEF 14A | View |
| 2025-08-25 | PRE 14A | View |
| 2025-08-18 | 424B5 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-05 | 8-K | View |
| 2025-07-29 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-03 | 8-K | View |
| 2025-05-28 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
Latest News on SILO